Literature DB >> 20519616

Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphism.

Gissel García1, Beatriz Sierra, Ana B Pérez, Eglys Aguirre, Ileana Rosado, Narjara Gonzalez, Alienys Izquierdo, Maritza Pupo, Didye Ruiz Danay Díaz, Lizet Sánchez, Beatriz Marcheco, Kenji Hirayama, María G Guzmán.   

Abstract

The role of human Fcgamma receptors (FcgammaR) has been recognized considerably over the last years. These receptors vary in their affinity for IgG subclasses and the intracellular signals elicited by them. Allelic variants of FcgammaR genes may influence the biological phagocyte activity, accounting for an inherited pre-disposition to disease. The specific FcgammaRIIa (CD32) contains a polymorphic variant (H/R131) that has been associated to a reduced risk for developing dengue hemorrhagic fever (DHF). Here, we investigated the role of this polymorphism in a very well-characterized group of Cuban individuals with antecedents of DHF, dengue fever (DF), or subclinical dengue infection. The HH131 genotype was significantly associated with dengue disease, either DF (*P = 0.016; odds ratio = 4.425; 95% confidence interval = 1.10-20.52) or DHF (P = 0.00018; odds ratio = 10.56; 95% confidence interval = 2.33-54.64) with respect to the subclinical infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20519616      PMCID: PMC2877427          DOI: 10.4269/ajtmh.2010.09-0353

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  27 in total

1.  Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations.

Authors:  T Lehrnbecher; C B Foster; S Zhu; S F Leitman; L R Goldin; K Huppi; S J Chanock
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

2.  Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?

Authors:  H Loke; D B Bethell; C X Phuong; M Dung; J Schneider; N J White; N P Day; J Farrar; A V Hill
Journal:  J Infect Dis       Date:  2001-11-13       Impact factor: 5.226

3.  MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination.

Authors:  Susana Vázquez; Odaysa Valdés; Maritza Pupo; Iselys Delgado; Mayling Alvarez; Jose Luis Pelegrino; Maria G Guzmán
Journal:  J Virol Methods       Date:  2003-06-30       Impact factor: 2.014

4.  Histocompatibility antigens and dengue hemorrhagic fever.

Authors:  P Chiewsilp; R M Scott; N Bhamarapravati
Journal:  Am J Trop Med Hyg       Date:  1981-09       Impact factor: 2.345

5.  Polymorphism of Fc receptor IIa for immunoglobulin G is associated with placental malaria in HIV-1-positive women in western Kenya.

Authors:  Kimberly C Brouwer; Altaf A Lal; Lisa B Mirel; Juliana Otieno; John Ayisi; Anne M Van Eijk; Renu B Lal; Richard Steketee; Bernard L Nahlen; Ya Ping Shi
Journal:  J Infect Dis       Date:  2004-08-17       Impact factor: 5.226

6.  Fc gamma RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patients.

Authors:  Ana Paula Bazilio; Vilma S T Viana; Rui Toledo; Viktoria Woronik; Eloisa Bonfá; Renato C Monteiro
Journal:  Nephrol Dial Transplant       Date:  2004-03-05       Impact factor: 5.992

Review 7.  FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy.

Authors:  N M van Sorge; W-L van der Pol; J G J van de Winkel
Journal:  Tissue Antigens       Date:  2003-03

8.  Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa.

Authors:  Graham S Cooke; Christophe Aucan; Andrew J Walley; Shelley Segal; Brian M Greenwood; Dominic P Kwiatkowski; Adrian V S Hill
Journal:  Am J Trop Med Hyg       Date:  2003-12       Impact factor: 2.345

Review 9.  Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications.

Authors:  J G van de Winkel; P J Capel
Journal:  Immunol Today       Date:  1993-05

10.  A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding.

Authors:  P A Warmerdam; J G van de Winkel; A Vlug; N A Westerdaal; P J Capel
Journal:  J Immunol       Date:  1991-08-15       Impact factor: 5.422

View more
  36 in total

Review 1.  The Role and Function of Fcγ Receptors on Myeloid Cells.

Authors:  Stylianos Bournazos; Taia T Wang; Jeffrey V Ravetch
Journal:  Microbiol Spectr       Date:  2016-12

Review 2.  Signaling by Antibodies: Recent Progress.

Authors:  Stylianos Bournazos; Taia T Wang; Rony Dahan; Jad Maamary; Jeffrey V Ravetch
Journal:  Annu Rev Immunol       Date:  2017-04-26       Impact factor: 28.527

3.  Genetic variants associated with severe pneumonia in A/H1N1 influenza infection.

Authors:  J Zúñiga; I Buendía-Roldán; Y Zhao; L Jiménez; D Torres; J Romo; G Ramírez; A Cruz; G Vargas-Alarcon; C-C Sheu; F Chen; L Su; A M Tager; A Pardo; M Selman; D C Christiani
Journal:  Eur Respir J       Date:  2011-07-07       Impact factor: 16.671

4.  Reply: Apropos "Dengue virus identification by transmission electron microscopy and molecular methods in fatal dengue hemorrhagic fever".

Authors:  D Limonta; V Capó; M G Guzmán
Journal:  Infection       Date:  2013-02-09       Impact factor: 3.553

5.  Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity.

Authors:  Molly OhAinle; Angel Balmaseda; Alexander R Macalalad; Yolanda Tellez; Michael C Zody; Saira Saborío; Andrea Nuñez; Niall J Lennon; Bruce W Birren; Aubree Gordon; Matthew R Henn; Eva Harris
Journal:  Sci Transl Med       Date:  2011-12-21       Impact factor: 17.956

6.  IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity.

Authors:  Taia T Wang; Jaturong Sewatanon; Matthew J Memoli; Jens Wrammert; Stylianos Bournazos; Siddhartha Kumar Bhaumik; Benjamin A Pinsky; Kulkanya Chokephaibulkit; Nattawat Onlamoon; Kovit Pattanapanyasat; Jeffery K Taubenberger; Rafi Ahmed; Jeffrey V Ravetch
Journal:  Science       Date:  2017-01-27       Impact factor: 47.728

7.  Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection.

Authors:  Kobporn Boonnak; Bonnie M Slike; Gina C Donofrio; Mary A Marovich
Journal:  J Immunol       Date:  2013-04-24       Impact factor: 5.422

8.  High prevalence of dengue antibodies and the arginine variant of the FcγRIIa polymorphism in asymptomatic individuals in a population of Minas Gerais State, Southeast Brazil.

Authors:  Anna Carolina Toledo da Cunha Pereira; Tatiane Ribeiro de Siqueira; Andressa Anunciação de Oliveira Prado; Camila Almeida Veiga da Silva; Thaís de Fátima Silva Moraes; Alan Alex Aleixo; José Carlos de Magalhaes; Gabriel Augusto Pires de Souza; Betânia Paiva Drumond; Gustavo Portela Ferreira; Breno de Mello Silva; Cintia Lopes de Brito Magalhães; Luciana Lara Santos; Jaqueline Maria Siqueira Ferreira; Luiz Cosme Cotta Malaquias; Luiz Felipe Leomil Coelho
Journal:  Immunogenetics       Date:  2017-11-21       Impact factor: 2.846

Review 9.  Beyond binding: antibody effector functions in infectious diseases.

Authors:  Lenette L Lu; Todd J Suscovich; Sarah M Fortune; Galit Alter
Journal:  Nat Rev Immunol       Date:  2017-10-24       Impact factor: 53.106

10.  Association of FcγRIIa Polymorphism with Clinical Outcome of Dengue Infection: First Insight from Pakistan.

Authors:  Saima Naz Mohsin; Saqib Mahmood; Ali Amar; Farkhanda Ghafoor; Syed Mohsin Raza; Mahjabeen Saleem
Journal:  Am J Trop Med Hyg       Date:  2015-08-03       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.